ArticleMolecular therapy. Oncology2024

TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs.

Qingyu Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.